financetom
Business
financetom
/
Business
/
New Boeing CEO seeks to restore trust, stay close to production
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
New Boeing CEO seeks to restore trust, stay close to production
Aug 8, 2024 5:37 AM

WASHINGTON (Reuters) - Boeing's ( BA ) new boss Kelly Ortberg will meet factory workers near Seattle on Thursday and pledged to be closer to the U.S. planemaker's production lines, as he faces the steep task of "restoring trust," according to a message to employees seen by Reuters.

The former Rockwell Collins boss on Thursday is taking over as head of the U.S. planemaker, which is bleeding cash and beset by company-wide problems expected to take years to fix.

Ortberg's extensive to-do list includes mending relationships with airlines and employees, boosting output, repairing company finances and securing a labor deal to avoid a possible worker strike this year.

Ortberg, 64, said he plans to be based in Seattle to be close to Boeing's ( BA ) commercial airplane programs, such as the 737 MAX whose production has slowed following a Jan. 5 mid-air panel blowout on a near-new model. Boeing ( BA ) is currently producing about 25 MAX jets a month, with a target of 38 per month by year-end.

"Because what we do is complex, I firmly believe that we need to get closer to the production lines and development programs across the company," he wrote in the letter. "In fact, I'll be on the factory floor in Renton today, talking with employees and learning about challenges we need to overcome."

Ortberg also plans to visit employees at Boeing's ( BA ) key supplier Spirit AeroSystems in Wichita, Kansas, next week, two sources familiar with the matter told Reuters. Last month Boeing ( BA ) agreed to buy back Spirit Aero, whose core plants it spun off in 2005, for $4.7 billion in stock.

"Soon I'll be visiting many of our sites and I look forward to meeting with teammates around the world," the letter said.

"Restoring trust starts with meeting our commitments -- whether that's building high quality, safe commercial aircraft, delivering on defense and space products that allow our customers to meet their mission," Ortberg added in the note.

"People's lives depend on what we do every day, and we must keep that top of mind with every decision we make."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Google Fiber Appoints John Abbot as CFO
--Street Color: Google Fiber Appoints John Abbot as CFO
May 28, 2024
01:05 PM EDT, 05/28/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 177.68, Change: +1.35, Percent...
Hess investors to vote on Chevron deal amid growing postponement calls
Hess investors to vote on Chevron deal amid growing postponement calls
May 28, 2024
HOUSTON (Reuters) - Hess Corp ( HES ) shareholders will vote on Tuesday on Chevron's ( CVX ) proposed $53 billion acquisition of the company, after many investors have called for a delay in hopes of obtaining a better offer for their shares. The vote has huge implications for both companies. The deal has been stalled in part by a...
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
May 28, 2024
Tuesday, Agios Pharmaceuticals Inc ( AGIO ) agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma Plc ( RPRX ) .  Under the terms of the agreement, Agios will receive an upfront payment of $905 million upon FDA approval of vorasidenib, and Royalty Pharma ( RPRX ) will receive the entirety of the 15% royalty on annual U.S. net sales...
Semler Scientific Stock Rallies after Adopting Bitcoin as Treasury Reserve Asset
Semler Scientific Stock Rallies after Adopting Bitcoin as Treasury Reserve Asset
May 28, 2024
01:05 PM EDT, 05/28/2024 (MT Newswires) -- Semler Scientific ( SMLR ) was surging nearly 31% during Tuesday trading after the marketing technology company said it will now use bitcoin as its primary treasury reserve asset after recently buying 581 bitcoins for $40 million. The decision reflects the company's belief that bitcoin is a reliable store of value and a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved